2N Pharma
2N Pharma develops novel therapeutic drugs for the treatment of ALS, Parkinson's and other neurodegenerative diseases.
Operating in biotechnology, pharmaceutical based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), 2N Pharma was founded in 2019.
Its activity falls under biotechnology, pharmaceutical; the profile below is assembled from public directory data.
The business is associated with European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Private company.
The company reports a headcount in the c_00001_00010 range.
| Sector | Biotechnology, Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2019 |
| Employees | c_00001_00010 |
| Stage | Private company |
Website: 2npharma.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account